Beam Therapeutics Inc. (BEAM) shares ended the last trading session 5.7% higher at $21.46. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the ...

Beam Therapeutics Inc. (NASDAQ:BEAM) is one of the 13 Best Pharma Stocks to Buy According to Wall Street Analysts. On July 1, ...

Beam Therapeutics (BEAM) is at the forefront of gene editing, a revolutionary medical technology that is drawing significant interest from investors worldwide due to its immense potential for ...

Beam Therapeutics is also expanding its genetic disease pipeline by developing BEAM-301 and BEAM-302 for treating glycogen storage disease type 1a (GSD1a) and alpha-1 antitrypsin deficiency (AATD ...

When it comes to gene-editing companies on the cutting edge, Beam Therapeutics (BEAM 0.99%) is keen to be one of the leaders. While it's a bit of a laggard in terms of its pipeline's maturity ...

We recently compiled a list of the 10 Best Gene Therapy Stocks to Buy Right Now. In this article, we are going to take a look at where Beam Therapeutics Inc. (NASDAQ:BEAM) stands against the other ...

Beam Therapeutics has a strong financial position with over $1 billion in cash and assets, but its high cash burn rate poses a risk. Caroline Purser/The Image Bank via Getty Images.

Beam Therapeutics Inc.'s stock is down roughly 35% since our first look at the company. Positive analyst coverage has certainly picked up around the company over the past few months.

On Oct. 19, the early-stage gene-editing biotech Beam Therapeutics (BEAM-1.98%) announced it would be slashing its workforce by 100 employees, or around 20% of its total, while also refocusing its ...

Beam Therapeutics. Beam Therapeutics , a Cambridge-based gene editing company working to combat sickle cell disease, is aiming to start human clinical research for its experimental treatment.

Beam Therapeutics Inc. (BEAM) shares ended the last trading session 5.7% higher at $21.46. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the ...